Trials / Active Not Recruiting
Active Not RecruitingNCT05152524
Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 168 (estimated)
- Sponsor
- Rapid Medical · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the DISTALS Study is to evaluate the safety and effectiveness of the Tigertriever 13 Revascularization Device in restoring blood flow in the neurovasculature by removing thrombus in patients presenting within 24 hours of onset with an ischemic stroke with disabling neurological deficits due to a primary distal vessel occlusion (DVO), as compared to medical management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Tigertriever 13 | patients presenting within 24 hours of onset with an ischemic stroke with disabling neurological deficits due to a primary distal vessel occlusion (DVO) will be treated with the Tigertriever 13 device. |
Timeline
- Start date
- 2022-03-25
- Primary completion
- 2025-12-01
- Completion
- 2026-03-01
- First posted
- 2021-12-10
- Last updated
- 2025-12-22
Locations
20 sites across 4 countries: United States, Belgium, Germany, Sweden
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05152524. Inclusion in this directory is not an endorsement.